Weeldreyer, Nathan R.
Foulkes, Stephen J.
Thompson, Richard B.
Pituskin, Edith
Haykowsky, Mark J.
Funding for this research was provided by:
Canadian Institutes of Health Research (183969)
Canadian Cancer Research Society
Article History
Received: 25 February 2026
Accepted: 15 June 2026
First Online: 9 September 2026
Declarations
Ethics approval and consent to participate: This trial has been approved by the Health Research Ethics Board of Alberta (HREBA.CC-24-0058) and prospectively registered with ClinicalTrials.gov (NCT06595147). Written informed consent will be provided before any study procedures occur.
Competing interests: The authors declare no competing interests.